磁共振波谱技术在乳腺癌诊断中的应用
Advances of magnetic resonance spectroscopy in breast cancer
摘要
乳腺癌是临床常见的恶性肿瘤之一,MR在乳腺癌的诊断中发挥着重要的作用。磁共振波谱技术是能检测体内生化代谢的微创性检查方法,本文介绍磁共振波谱在乳腺癌诊断和评价治疗效果中的应用现状。
Breast cancer is one of the most common malignant tumor in women. MRI plays an important role in diagnosis of breast cancer. Magnetic resonance spectroscopy (MRS) could show biochemistry metabolism in vivo. This article reviews the applications of MRS for diagnosis in breast cancer and assesment of therapy.
出处
《医学影像学杂志》
2006年第12期1302-1304,共3页
Journal of Medical Imaging
关键词
乳腺癌
磁共振波谱
Breast cancer
Magnetic resonance spectroscopy
参考文献15
-
1Ronen SM,Leach MO.Imaging biochemistry:applications to breast cancer[J].Breast Cancer Res,2001,3:36-40.
-
2张帅,周正荣,彭卫军.磁共振波谱在乳腺肿瘤中的应用进展[J].临床放射学杂志,2005,24(4):373-375. 被引量:4
-
3Leach MO,Verrill M,Glaholm J,et al.Measurements of human breast cancer using magnetic resonance spectroscopy:a review of clinical measurements and a report of localized 31P measurements of response to treatment[J].NMR Biomed,1998,11:314-340.
-
4Merchant TE,Kasimos JN,Vroom T,et al.Malignant breast tumor phospholipid profiles using (31)P magnetic resonance[J].Cancer Lett,2002,176:159-167.
-
5Glunde K,Jie C,Bhujwalla ZM.Molecular causes of the aberrant choline phospholipid metabolism in breast cancer[J].Cancer Res,2004,64:4270-4276.
-
6Beloueche-Babari M,Jackson LE,Al-Saffar NM,et al.Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells[J].Mol Cancer Ther,2006,5:187-196.
-
7Star Lack JM,Adalsteinsson E,et a1.Motion correction and lipid suppression for 1H magnetic resonance spectroscopy[J].Magn Reson Med,2000,43:325-330.
-
8Stanwell P,Gluch L,Clark D,et a1.Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H-MRS at 1.5T[J].Eur Radio1,2005,15:1037-1043.
-
9Kim JK,Park SH,Lee HM,et al.In vivo 1H-MRS evaluation of malignant and benign breast diseases[J].Breast,2003,12:179-182.
-
10Katz-Brull R,Lavin PT,Lenkinski RE.Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions[J].J Natl Cancer Inst,2002,94:1197-1203.
二级参考文献25
-
1Singer S, Souza K. Pyruvate utilization, phosphocholine and adenosine triphosphate(ATP) are makers of human breast tumor progression: a 31P and 13C nuclear magnetic resonance (NMR) spectroscopy study. Cancer Res, 1995, 55:5140
-
2Payne GS, Dowsett M, Leach MO. Hornone-dependent metabolic changes in the normal breast monitored non invasively by 31P magnetic resonance (MR) spectroscopy. Breast, 1994, 3:20
-
3Twelves CJ, Porter DA, Lowry M,et al. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy. Br J Cancer, 1994, 69:1151
-
4Kvistad KA, Bakken IJ, Gribbested IS,et al. Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy. J Magn. Reson Imaging, 1999, 10:159
-
5Smith TA, Eccles S, Ormerod MG,et al. The phosphochline and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. Br J Cancer, 1991, 64:821
-
6Ting YL, Sherr D, Degani H. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res, 1996, 16:1381
-
7Smith TA, Glaholm J, Leach MO,et al. The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy. NMR Biomed, 1991, 4:262
-
8Cheng LL, Chang IW, Smith BL,et al. Evaluating human breast ductal carcinomas with high-resolution magnic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson, 1998, 135:194
-
9Gribbestad IS, Sitter B, Lundgren S,et al. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res, 1999, 19:1737
-
10Brull RK, Seger D, Segal DR,et al. Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Res, 2002, 62:1966
共引文献3
-
1颜荣华,肖恩华,梁斌.1.5 T磁共振兔VX2肝癌活体二维多体素1H-MRS应用初探[J].临床放射学杂志,2005,24(12):1097-1102. 被引量:10
-
2罗晓雯,孔祥泉.乳腺磁共振波谱研究的进展[J].放射学实践,2007,22(8):882-884. 被引量:4
-
3高秀香,徐怡庄,赵梅仙,齐剑,李慧珍,吴瑾光.核磁共振波谱在肿瘤诊疗中的应用研究进展[J].光谱学与光谱分析,2008,28(8):1942-1950. 被引量:16
-
1余长亮.磁共振波谱技术及其临床应用[J].中国医学影像技术,1999,15(3):229-230. 被引量:6
-
2刘玉品,杨小庆.磁共振波谱技术在乳腺肿瘤中的应用[J].实用放射学杂志,2003,19(10):886-888. 被引量:7
-
3贺国珠,毕会英,吕庆波.磁共振影像技术及磁共振波谱技术在医学中的应用[J].新乡医学院学报,1997,14(2):158-161.
-
4肖勇.磁共振弥散加权成像联合磁共振波谱技术对4ng/ml≤PSA≤20ng/ml前列腺癌诊断的价值[J].现代医用影像学,2016,25(6):1029-1031. 被引量:2
-
5刘森,于金明.PET显像评价头颈部肿瘤放射治疗疗效的研究现状[J].中华核医学杂志,2005,25(3):188-191. 被引量:4
-
6李兆斌,傅深.磁共振波谱技术在放射治疗靶区确定及疗效监测中的应用[J].中国癌症杂志,2010,20(5):393-396. 被引量:1
-
7杜飞舟,丁仕义.磁共振波谱分析在骨及软组织肿瘤中的应用[J].实用放射学杂志,2007,23(10):1424-1426. 被引量:1
-
8吴坚,高元桂,杨立.心脏磁共振波谱分析的临床应用[J].中国医学影像学杂志,2006,14(2):146-148. 被引量:1
-
9刘春梅.肝脏脂肪含量测定方法[J].医疗装备,2016,29(18):191-192.
-
10刘强,李保朋,李子俊.磁共振波谱技术在肿瘤基因治疗效果评价中的应用价值[J].中华临床医师杂志(电子版),2009,3(3):58-61. 被引量:2